|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2001-3-21
|
|
pubmed:abstractText |
Tamoxifen and its analogues act as selective estrogen receptor modulators (SERMs) in women, with estrogen-like activities on some plasma cardiovascular risk factors (eg, lipoproteins). Effects of SERMs on men with coronary artery disease (CAD) have not been reported.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1497-502
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11257075-Aged,
pubmed-meshheading:11257075-Arteriosclerosis,
pubmed-meshheading:11257075-Brachial Artery,
pubmed-meshheading:11257075-Endothelium, Vascular,
pubmed-meshheading:11257075-Estradiol,
pubmed-meshheading:11257075-Estrogen Antagonists,
pubmed-meshheading:11257075-Humans,
pubmed-meshheading:11257075-Lipids,
pubmed-meshheading:11257075-Male,
pubmed-meshheading:11257075-Middle Aged,
pubmed-meshheading:11257075-Risk Factors,
pubmed-meshheading:11257075-Tamoxifen,
pubmed-meshheading:11257075-Testosterone,
pubmed-meshheading:11257075-Vasodilation
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis.
|
|
pubmed:affiliation |
Department of Cardiology, Papworth Hospital NHS Trust, Papworth Everard, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
